Evaluation of a digital diabetes prevention program adapted for the Medicaid population: Study design and methods for a non-randomized, controlled trial.

Autor: Kim SE; Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, SSB 2001 N. Soto Street, Los Angeles, CA 90033, USA., Castro Sweet CM; Omada Health, Inc., 500 Sansome Street, Suite 200, San Francisco, CA 94111, USA., Gibson E; Omada Health, Inc., 500 Sansome Street, Suite 200, San Francisco, CA 94111, USA., Madero EN; Omada Health, Inc., 500 Sansome Street, Suite 200, San Francisco, CA 94111, USA., Rubino B; LAC+USC Medical Center, 2015 Marengo Street, Los Angeles, CA 90033, USA., Morrison J; LAC+USC Medical Center, 2015 Marengo Street, Los Angeles, CA 90033, USA., Rosen D; Northeast Valley Health Corporation, 1172 North Maclay Avenue, San Fernando, CA 91340, USA., Imberg W; Providence Medical Group, Monroe Clinic, 19200 North Kelsey Street, Monroe, WA 98272, USA., Cousineau MR; Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, SSB 2001 N. Soto Street, Los Angeles, CA 90033, USA.
Jazyk: angličtina
Zdroj: Contemporary clinical trials communications [Contemp Clin Trials Commun] 2018 May 06; Vol. 10, pp. 161-168. Date of Electronic Publication: 2018 May 06 (Print Publication: 2018).
DOI: 10.1016/j.conctc.2018.05.007
Abstrakt: Previous studies have shown that lifestyle modification can successfully prevent or delay development of type 2 diabetes. This trial aimed to test if an underserved, low-income population would engage in a digital diabetes prevention program and successfully achieve lifestyle changes to reduce their risk of type 2 diabetes. Participants were recruited from three health care facilities serving low-income populations. The inclusion criteria were: a recent blood test indicating prediabetes, body mass index (BMI) > 24 kg/m 2 , age 18-75 years, not pregnant, not insured, Medicaid insured or Medicaid-eligible, internet or smartphone access, and comfort reading and writing in English or Spanish. A total of 230 participants were enrolled and started the intervention. Participants' average age was 48 years, average BMI = 34.8, average initial HbA1c = 5.8, 81% were female, and 45% were Spanish speaking. Eighty percent had Medicaid insurance, 18% were uninsured, and 2% were insured by a medical safety net plan. Participants completed a health assessment including measured anthropometrics, HbA1c test, and self-report questionnaires at baseline, 6 and 12 months. The 52-week digital diabetes prevention program included weekly educational curriculum, human health coaching, connected tracking tools, and peer support from a virtual group. Qualitative data on implementation was collected with semi-structured interviews with key informants to understand the barriers, keys to success, and best practices in the adoption of the program within the clinical setting. This paper describes the study design and methodology of a digital diabetes prevention program and early lessons learned related to recruitment, enrollment, and data collection.
Databáze: MEDLINE